18 and older, any sex, with Dementia or Chronic Disease. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
EHR Documentation of Goals of Care DiscussionsPrimary· from randomization to 30 days post randomization
The primary outcome is the proportion of patients who have a goals-of-care discussion that has been documented in the electronic medical record (EHR) in the period between randomization and 30 days following randomization. The proportion is the number of patients with goals-of-care (GOC) documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our natural language processing/machine learning (NLP/ML) methods.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.271
EHR Based Clinician-facing Jumpstart Guide Intervention
0.317
Usual Care: No Intervention
0.206
Intensity of Care: ICU Admissions (30 Days)Secondary· from randomization to 30 days post randomization
Any new ICU admissions or readmissions collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.0887
± 0.302
EHR Based Clinician-facing Jumpstart Guide Intervention
0.0634
± 0.282
Usual Care: No Intervention
0.0622
± 0.279
Intensity of Care: ICU Admissions (90 Days)Secondary· from randomization to 90 days post randomization
Any new ICU admissions or readmissions collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.118
± 0.367
EHR Based Clinician-facing Jumpstart Guide Intervention
0.117
± 0.391
Usual Care: No Intervention
0.0957
± 0.354
Intensity of Care: ICU Admissions (Post-discharge, 7 Days)Secondary· 7-days post-discharge
Any ICU admissions or readmissions collected from the EHR. Censored at 90 days post-randomization.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.015
± 0.121
EHR Based Clinician-facing Jumpstart Guide Intervention
0.010
± 0.099
Usual Care: No Intervention
0.000
± 0.000
Intensity of Care: ICU Admissions (Post-discharge, 30 Days)Secondary· 30-days post-discharge
Any ICU admissions or readmissions collected from the EHR. Censored at 90 days post-randomization.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.030
± 0.170
EHR Based Clinician-facing Jumpstart Guide Intervention
0.034
± 0.207
Usual Care: No Intervention
0.024
± 0.153
Intensity of Care: Hospital Readmissions (7 Days)Secondary· readmissions in 7 days following discharge
Any hospital readmissions in 7 days following discharge; collected from the EHR. Censored at 90 days post-randomization.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.0394
± 0.195
EHR Based Clinician-facing Jumpstart Guide Intervention
0.0732
± 0.261
Usual Care: No Intervention
0.0766
± 0.267
Intensity of Care: Hospital Readmissions (30 Days)Secondary· readmissions in 30 days following discharge
Any hospital readmissions in 30 days following discharge collected from the EHR. Censored at 90 days post-randomization.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
0.128
± 0.335
EHR Based Clinician-facing Jumpstart Guide Intervention
0.176
± 0.463
Usual Care: No Intervention
0.230
± 0.475
Intensity of Care: ICU Free Days (30 Days)Secondary· from randomization to 30 days post randomization
Number of days alive and out of the ICU within 30 days from randomization, collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
28.1
± 5.81
EHR Based Clinician-facing Jumpstart Guide Intervention
27.9
± 6.17
Usual Care: No Intervention
28.5
± 4.72
Intensity of Care: ICU Free Days (90 Days)Secondary· from randomization to 90 days post randomization
Number of days alive and out of the ICU within 90 days from randomization, collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
83.8
± 19.3
EHR Based Clinician-facing Jumpstart Guide Intervention
79.9
± 24.3
Usual Care: No Intervention
83.1
± 19.5
Intensity of Care: Hospital Free Days (30 Days)Secondary· from randomization to 30 days post randomization
Number of days alive and out of the hospital within 30 days from randomization; collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
21.6
± 8.42
EHR Based Clinician-facing Jumpstart Guide Intervention
20.8
± 9.16
Usual Care: No Intervention
20.8
± 8.51
Intensity of Care: Hospital Free Days (90 Days)Secondary· from randomization to 90 days post randomization
Number of days alive and out of the hospital within 90 days from randomization; collected from the EHR.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
75.2
± 21.6
EHR Based Clinician-facing Jumpstart Guide Intervention
70.5
± 26.6
Usual Care: No Intervention
71.6
± 24.4
Patient or Surrogate/Family-reported Discussion of Goals (3-5 Days)Secondary· 3-5 days after randomization
Subjects will self-report (yes or no) if they had a discussion of goals of care ("the kind of medical care you/your loved one would want") during the index hospitalization. Responses of "unsure" are included in the sample and not counted as missing. This outcome is presented as a proportion: the number of participants reporting a goals-of-care discussion over the number of patients in each study arm.
Group
Value
95% CI
Survey Based Bi-directional Jumpstart Guide Intervention
48
EHR Based Clinician-facing Jumpstart Guide Intervention
39
Usual Care: No Intervention
62
Sponsor's own description
The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over time, and across settings and providers. This study is particularly interested in understanding the effect of the intervention to improve quality of palliative care for patients with Alzheimer's disease and related dementias (ADRD) but will also include other common chronic, life-limiting illnesses.
The specific aims are:
1. To evaluate the efficacy of the EHR-based clinician-facing Jumpstart, drawn from the electronic medical record (EHR), the survey-based bi-directional Jumpstart, drawn from patient or family completed surveys, and usual care for improving quality of care provided to patients with chronic illness experiencing a hospitalization. The primary outcome is EHR documentation of a goals-of-care discussion, assessed from randomization through 30 days. Secondary outcomes include: a) intensity of care outcomes (e.g., ICU use, ICU and hospital free days, hospital readmissions, costs of hospital care); and b) patient- and family-reported outcomes assessed by surveys at 3-5 days and 4-6 weeks after randomization, including occurrence and quality of goals-of-care discussions in the hospital, goal-concordant care, psychological symptoms, and quality of life.
2. To conduct a mixed-methods evaluation of the implementation of the interventions, guided by the RE-AIM and CFIR frameworks for implementation science, incorporating quantitative evaluation of the interventions' reach and adoption, as well as qualitative analyses of interviews with participants, to explore barriers and facilitators to future implementation and dissemination.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia
· NA
· recruiting
NCT07290387 — Tele-Savvy for Latino Caregivers
· NA
· recruiting
NCT06088810 — The Impact of Music Intervention on Sleep
· NA
· recruiting
NCT07482800 — Dementia in Fiction and Clinical Narratives
· recruiting
NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home
· NA
· recruiting
Other University of Washington trials
Trials by the same sponsor.
NCT07430852 — Inherited and Environmental Risks Acting on Body Weight
· NA
· not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc
· Phase 2
· not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn
· NA
· not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
· Phase 2
· not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle
· Phase 2
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 24 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04283994.